The accessory genes, vpr and vpx, are highly conserved across primate lentiviral lineages. Several genetically and functionally separable properties have been described for these accessory proteins. HIV-1 Vpr has been implicated in nuclear translocation of viral reverse transcription complexes. In addition, this protein causes a delay in the G2 phase of the cell cycle and has additionally been shown to associate with the DNA repair enzyme, uracil DNA glycosylase. These properties are segregated between Vpr and Vpx of HIV-2/SIVSM in that Vpr influences cell cycle progression and associates with UDG, whereas, Vpx promotes nuclear translocation of viral cDNA in nondividing macrophages. Studies completed in the previous funding period have underscored the notion that nuclear targeting activities of HIV-1 Vpr and its analogous activity in HIV-2/SIVSM Vpx have evolved to permit efficient virus replication in primary macrophages both in vitro and in vivo. Without information on functional domains in Vpr/Vpx proteins which regulate their activities is that mutations in activating Vpr and Vpx alleles may compromise possible additional as yet unidentified functions to more rigorously connect the replication defect in vivo imposed by the Vpx mutation with impaired nuclear import in nondividing macrophages would require the identification of defined mutants which specifically impair the nuclear import activity of these proteins. The object of this proposal is to more rigorously establish the contribution of nuclear transport activities of Vpr/Vpx proteins to primate lentiviral pathogenicity. Specifically, we propose to:
Aim 1 : Identify effector domains for nuclear localization of HIV-1 Vpr and SIVSM Vpx and for association of Vpr/Vpx with viral reverse transcription complexes.
Aim 2 : Characterize the pathway through which nuclear localization of Vpr/Vpx proteins is directed and identify the potential role of bridging proteins in the interaction of Vpr/Vpx with the nuclear import apparatus.
Aim 3 : Examine the phenotype of nuclear import mutants of HIV-1 and SIV in macrophage infection.
Aim 4 : Examine the relative in vivo fitness of SIVSM Vpx mutants which are impaired in nuclear import. It is expected that these studies will more fully define the contribution of nuclear import activities of Vpr and i Vpx proteins to virus replication in vitro and in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI037475-16
Application #
7584199
Study Section
Special Emphasis Panel (NSS)
Program Officer
Sharma, Opendra K
Project Start
1995-05-01
Project End
2010-03-31
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
16
Fiscal Year
2009
Total Cost
$377,879
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Brandano, Laura; Stevenson, Mario (2012) A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J Virol 86:2347-59
Kaushik, Rajnish; Zhu, Xiaonan; Stranska, Ruzena et al. (2009) A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 6:68-80
Zielske, Steven P; Stevenson, Mario (2006) Modest but reproducible inhibition of human immunodeficiency virus type 1 infection in macrophages following LEDGFp75 silencing. J Virol 80:7275-80
Zielske, Steven P; Stevenson, Mario (2005) Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. J Virol 79:11541-6
Triques, Karine; Stevenson, Mario (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 78:5523-7
Chiu, Ya-Lin; Cao, Hong; Jacque, Jean-Marc et al. (2004) Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol 78:2517-29
Somasundaran, Mohan; Sharkey, Mark; Brichacek, Beda et al. (2002) Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A 99:9503-8
Sleigh, R; Sharkey, M; Newman, M A et al. (1998) Differential association of uracil DNA glycosylase with SIVSM Vpr and Vpx proteins. Virology 245:338-43
Hirsch, V M; Sharkey, M E; Brown, C R et al. (1998) Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med 4:1401-8
Fletcher 3rd, T M; Brichacek, B; Sharova, N et al. (1996) Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J 15:6155-65